Ledger.Open graph →
SEC Form D · Amendment · filed December 1, 2016

Neurovance, Inc

Offering
$16.0M
Sold
$7.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Jeffrey L. Bailey · Cambridge, MAExec · DirectorCampbell A. Murray · Cambridge, MADirectorGregg T. Beloff · Cambridge, MAExecWilliam T. Pappafotopoulos · Cambridge, MAExecBrigitte A. Smith · Melbourne VIC, Channel IslandsDirectorAlbert L. Sokol · Boston, MAExecPaul A. Weiss · Madison, WIDirectorDaniel A. Omstead · Boston, MADirectorTimothy J. Barberich · Concord, MADirectorAnthony A. Mckinney · Cambridge, MAExecJames W. Judson · Seattle, WAExecR. D. Newton · Plano, TXDirectorChris J. O'Reilly · Atlanta, GAExec · DirectorSusan Oh · Denver, CODirectorZiwang Xu · HOUSTON, TXExecColin Carr · Lone Tree, COExecBrett D. Forman · Palm Beach, FLDirectorMichael A. Groneberg · MINNEAPOLIS, MNDirectorGeoff Huber · MINNEAPOLIS, MNExecTroy L. Beckett · Houston, TXExec · DirectorAnna M. Lantz · Houston, TXDirectorPaul Stevenson · Smiths, BermudaDirectorCharles Thomas · Grand Cayman, Cayman IslandsDirectorJohn Mcpheters · New York, NYExec · DirectorRichard F. Blubaugh · Greenwood Village, COExecDelome Fair · HOUSTON, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗